705 related articles for article (PubMed ID: 17574054)
1. The comparative safety of oral versus intranasal desmopressin for the treatment of children with nocturnal enuresis.
Robson WL; Leung AK; Norgaard JP
J Urol; 2007 Jul; 178(1):24-30. PubMed ID: 17574054
[TBL] [Abstract][Full Text] [Related]
2. Is there still a role for desmopressin in children with primary monosymptomatic nocturnal enuresis?: a focus on safety issues.
Van de Walle J; Van Herzeele C; Raes A
Drug Saf; 2010 Apr; 33(4):261-71. PubMed ID: 20297859
[TBL] [Abstract][Full Text] [Related]
3. Evidence of partial anti-enuretic response related to poor pharmacodynamic effects of desmopressin nasal spray.
De Guchtenaere A; Raes A; Vande Walle C; Hoebeke P; Van Laecke E; Donckerwolcke R; Vande Walle J
J Urol; 2009 Jan; 181(1):302-9; discussion 309. PubMed ID: 19013601
[TBL] [Abstract][Full Text] [Related]
4. Desmopressin associated symptomatic hyponatremic hypervolemia in children. Are there predictive factors?
Thumfart J; Roehr CC; Kapelari K; Querfeld U; Eggert P; Müller D
J Urol; 2005 Jul; 174(1):294-8; discussion 298. PubMed ID: 15947670
[TBL] [Abstract][Full Text] [Related]
5. Re: desmopressin toxicity due to prolonged half-life in 18 patients with nocturnal enuresis. J. L. Dehoorne, A. M. Raes, E. van Laecke, P. Hoebeke and J. G. Vande Walle J Urol 2006; 176: 754-758.
Nørgaard JP; Osterberg O; Holdrup L
J Urol; 2007 Mar; 177(3):1204; author reply 1204-5. PubMed ID: 17296451
[No Abstract] [Full Text] [Related]
6. The effect of desmopressin on renal water and solute handling in desmopressin resistant monosymptomatic nocturnal enuresis.
Kamperis K; Rittig S; Radvanska E; Jørgensen KA; Djurhuus JC
J Urol; 2008 Aug; 180(2):707-13; discussion 713-4. PubMed ID: 18554642
[TBL] [Abstract][Full Text] [Related]
7. A randomised comparison of oral desmopressin lyophilisate (MELT) and tablet formulations in children and adolescents with primary nocturnal enuresis.
Lottmann H; Froeling F; Alloussi S; El-Radhi AS; Rittig S; Riis A; Persson BE
Int J Clin Pract; 2007 Sep; 61(9):1454-60. PubMed ID: 17655682
[TBL] [Abstract][Full Text] [Related]
8. Intranasal desmopressin-induced hyponatremia.
Williford SL; Bernstein SA
Pharmacotherapy; 1996; 16(1):66-74. PubMed ID: 8700794
[TBL] [Abstract][Full Text] [Related]
9. Desmopressin toxicity due to prolonged half-life in 18 patients with nocturnal enuresis.
Dehoorne JL; Raes AM; van Laecke E; Hoebeke P; Vande Walle JG
J Urol; 2006 Aug; 176(2):754-7; discussion 757-8. PubMed ID: 16813936
[TBL] [Abstract][Full Text] [Related]
10. Partial response to intranasal desmopressin in children with monosymptomatic nocturnal enuresis is related to persistent nocturnal polyuria on wet nights.
Raes A; Dehoorne J; Van Laecke E; Hoebeke P; Vande Walle C; Vansintjan P; Donckerwolcke R; Vande Walle J
J Urol; 2007 Sep; 178(3 Pt 1):1048-51; discussion 1051-2. PubMed ID: 17632162
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of two sublingual types of desmopressin in 6-year-old and more children with primary nocturnal enuresis. About an international randomized cross-over study].
Lottmann H
Prog Urol; 2009 Feb; 19(2):132-8. PubMed ID: 19168019
[TBL] [Abstract][Full Text] [Related]
12. Severe hyponatremia due to desmopressin.
Kelleher HB; Henderson SO
J Emerg Med; 2006 Jan; 30(1):45-7. PubMed ID: 16434334
[TBL] [Abstract][Full Text] [Related]
13. The efficacy and safety of oral desmopressin in children with primary nocturnal enuresis.
Schulman SL; Stokes A; Salzman PM
J Urol; 2001 Dec; 166(6):2427-31. PubMed ID: 11696804
[TBL] [Abstract][Full Text] [Related]
14. Did the removal of the indication of nocturnal enuresis for intranasal desmopressin change prescribing practice?
Hoffmann F; Glaeske G; Steuber C
Pharmacoepidemiol Drug Saf; 2011 Jan; 20(1):105-9. PubMed ID: 21182158
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of a tertiary center enuresis population, with special emphasis on the relation among nocturnal diuresis, functional bladder capacity and desmopressin response.
Dehoorne JL; Walle CV; Vansintjan P; Raes AM; De Guchtenaere AR; Van Laecke E; Hoebeke P; Vande Walle JG
J Urol; 2007 Mar; 177(3):1130-7. PubMed ID: 17296432
[TBL] [Abstract][Full Text] [Related]
16. [Role of prescribing doctor in hyponatremic seizures of enuretic children on desmopressin].
Ecoffey M; Merz A; Egli D; Panchard MA; Laubscher B
Arch Pediatr; 2006 Mar; 13(3):262-5. PubMed ID: 16443352
[TBL] [Abstract][Full Text] [Related]
17. Severe signs of hyponatremia secondary to desmopressin treatment for enuresis: a systematic review.
Lucchini B; Simonetti GD; Ceschi A; Lava SA; Faré PB; Bianchetti MG
J Pediatr Urol; 2013 Dec; 9(6 Pt B):1049-53. PubMed ID: 23619353
[TBL] [Abstract][Full Text] [Related]
18. Intranasal desmopressin-associated hyponatremia: a case report and literature review.
Bernstein SA; Williford SL
J Fam Pract; 1997 Feb; 44(2):203-8. PubMed ID: 9040524
[TBL] [Abstract][Full Text] [Related]
19. Comparison of incidence of hyponatremia between intranasal and oral desmopressin in patients with central diabetes insipidus.
Kataoka Y; Nishida S; Hirakawa A; Oiso Y; Arima H
Endocr J; 2015; 62(2):195-200. PubMed ID: 25382102
[TBL] [Abstract][Full Text] [Related]
20. Desmopressin 30 years in clinical use: a safety review.
Vande Walle J; Stockner M; Raes A; Nørgaard JP
Curr Drug Saf; 2007 Sep; 2(3):232-8. PubMed ID: 18690973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
